Dr. Frederick M. Costello, MD
Interventional Cardiology (Interventional Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- University of Washington School of Medicine (2001)
- Years since graduation
- 25
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 613
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2001Medical school: University of Washington School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Interventional Cardiology Physician primary
ID license M10231 -
Internal Medicine Physician
NC license 200400112
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- St Luke's Regional Medical Center Boise, ID
- Saint Alphonsus Regional Medical Center Boise, ID
- St Luke's Nampa Medical Center Nampa, ID
- St Luke's Mccall Mccall, ID
- Treasure Valley Hospital Boise, ID
Medical groups
- High Desert Heart and Vascular (10 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 613
- Services billed
- 9,061
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 355 | 287 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 169 | 167 |
| Established patient office or other outpatient visit, 30-39 minutes | 125 | 113 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 116 | 111 |
| Established patient office or other outpatient visit, 40-54 minutes | 71 | 57 |
| New patient office or other outpatient visit, 45-59 minutes | 54 | 54 |
| Established patient office or other outpatient visit, 20-29 minutes | 49 | 48 |
| New patient office or other outpatient visit, 60-74 minutes | 44 | 44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 43 | 40 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 28 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Boise, ID | 130 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Boise, ID | 128 |
| Metoprolol Succinate Other prescribers in Boise, ID | 104 |
| Atorvastatin Calcium Other prescribers in Boise, ID | 102 |
| Amlodipine Besylate Other prescribers in Boise, ID | 92 |
| Losartan Potassium Other prescribers in Boise, ID | 77 |
| Lisinopril Other prescribers in Boise, ID | 62 |
| Rosuvastatin Calcium Other prescribers in Boise, ID | 57 |
| Carvedilol Other prescribers in Boise, ID | 45 |
| Jardiance (empagliflozin) Other prescribers in Boise, ID | 44 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 12 companies reported 31 payments worth $807 in total to this clinician.
| Medtronic, Inc. | $208 |
|---|---|
| Bridgebio Pharma, Inc. | $96.18 |
| Abiomed | $93.22 |
| Novartis Pharmaceuticals Corporation | $84.72 |
| Recor Medical Inc | $76.09 |
| E.r. Squibb & Sons, L.l.c. | $65.16 |
| AstraZeneca Pharmaceuticals LP | $49.92 |
| Boston Scientific Corporation | $41.94 |
| Food and Beverage | $807 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.